ArticleCase reports in psychiatry2026
Atomoxetine-Associated Bilateral Testicular Pain and Priapism in a Patient Taking Aripiprazole: A Case Report.
Article in Case reports in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Atomoxetine-Associated Bilateral Testicular Pain and Priapism in a Patient Taking Aripiprazole: A Case Report.Case reports in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Priapism, a urologic emergency, is defined as a penile erection persisting longer than 4 h independent of sexual stimulation. While psychotropic medication-associated priapism is well documented, atomoxetine-associated priapism remains extremely rare. Atomoxetine is a norepinephrine reuptake inhibitor used in the management of attention-deficit/hyperactivity disorder (ADHD). We report the case of an Asian male in his late 20s with bipolar I disorder who had been treated with aripiprazole 7.5 mg daily for 6 months and developed sudden bilateral testicular pain, followed by a painful erection lasting more than 4 h, beginning 5 days after starting atomoxetine. He had no history of genitourinary trauma, malignancy, or concurrent medication or substance use. Clinical and laboratory evaluation were unremarkable, and detumescence occurred approximately 6 h after symptom onset without invasive intervention. Atomoxetine was discontinued the next day and no recurrence was reported at 4-week follow-up. Causality assessment using the Naranjo Adverse Drug Reaction Probability Scale yielded a score of 4 (possible) for atomoxetine. This case underscores the importance of counseling patients prescribed atomoxetine and other psychotropics about priapism and the need for urgent evaluation when erections persist for ≥4 h.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.